Gene therapy shows promise in reducing HIV

(Reuters) - An early stage trial of Sangamo BioSciences Inc's HIV treatment found that the gene therapy reduced levels of the virus and even eliminated it in one patient with a naturally occurring gene mutation.
 

Sangamo gene therapy shows promise in reducing HIV

(Reuters) - An early stage trial of Sangamo BioSciences Inc's HIV treatment found that the gene therapy reduced levels of the virus and even eliminated it in one patient with a naturally occurring gene mutation.
 

EU court backs angry honeymaker in GM pollen row

The presence of pollen from GM maize in honey, even in minuscule quantities, renders farm produce commercially void in the European Union, the bloc's top court said Tuesday.
 

Grain companies tighten GMO policy, eye Syngenta corn

CHICAGO (Reuters) - Major U.S. grain companies have tightened curbs on genetically modified grains not yet approved by foreign markets, with some singling out one popular corn variety made by Syngenta, fearing any trace of the biotech grain in shipments could shut off export markets.
 

GMO corn falls prey to bugs it was supposed to thwart

A voracious pest which has long plagued corn farmers is devouring a widely-used variety that was genetically modified to thwart the rootworms, raising fears of a new superbug.
 

Insight: Next big drug against cholesterol takes shape

NEW YORK (Reuters) - A handful of drugmakers are racing to develop a new class of medicines they believe could be the biggest weapon against heart disease since statins were introduced in the 1980s.
 

Polish president vetoes bill allowing GMO seeds

WARSAW (Reuters) - Poland's President Bronislaw Komorowski on Wednesday vetoed a new legislation that would allow some genetically modified seeds in the country, saying it ran against European Union rules.
 

Forest Labs fends off Icahn at annual meeting

NEW YORK (Reuters) - Forest Laboratories Inc <FRX.N> won its showdown with activist investor Carl Icahn on Thursday, saying shareholders backed the company's slate of 10 board members over nominees proposed by the billionaire.
 

Data 'matchmaker' finds new uses for drugs

US scientists have devised a drug-disease matchmaking program that mines databases for potentially useful new treatment combinations and has turned up two so far, said a study on Wednesday.
 

Mercury-loving bugs speed help for toxic spills

Scientists say they have engineered bacteria that can mop up mercury, a step forward in the goal of using "bioremediation" to cleanse toxic chemicals from the environment.
 

Gene therapy shown to destroy leukemia tumors

LOS ANGELES (Reuters) - Scientists for the first time have used gene therapy to successfully destroy cancer tumors in patients with advanced disease -- a goal that has taken 20 years to achieve.
 

Monsanto plans farm trials for drought-tolerant corn

ST. LOUIS, Missouri (Reuters) - Monsanto Co. will begin farm trials of its drought-tolerant corn seed next spring, marking the global seed giant's first roll-out of seeds genetically engineered for harsh environmental conditions.
 

Few replicas as first cloned cat nears 10

Nearly 10 years after scientists cloned the first cat, predictions of a vast commercial market for the "resurrection" of beloved pets through cloning have fallen flat.
 

Australia farmer sues neighbours over GM crops

An Australian farmer on Thursday launched legal action against his neighbour after genetically modified canola blew onto his farm, prompting authorities to strip him of his organic licence.
 

South Korean scientists create glowing dog: report

SEOUL (Reuters) - South Korean scientists said on Wednesday they have created a glowing dog using a cloning technique that could help find cures for human diseases such as Alzheimer's and Parkinson's, Yonhap news agency reported.
 

U.S. judge upholds federal embryonic stem cell funds

WASHINGTON (Reuters) - A U.S. judge Wednesday upheld the government rules that allow federal funding of human embryonic stem cell research that may lead to cures for deadly diseases affecting millions of Americans.
 

Korean scientists create glowing dog: report

SEOUL (Reuters) - South Korean scientists said on Wednesday they have created a glowing dog using a cloning technique that could help find cures for human diseases such as Alzheimer's and Parkinson's, Yonhap news agency reported.
 

Greenpeace Australia raided over GM wheat action

Australian police on Thursday raided the Sydney offices of Greenpeace over their destruction of an experimental crop of genetically modified wheat at a government research farm.
 

Japan researchers grow tooth in mouse kidney

Japanese bio engineers have succeeded in growing a tooth from cells implanted into a mouse kidney, using a technique that could create replacement organs faster than previously tested methods.
 

Tests start on HIV biotech drug - grown in tobacco

LONDON (Reuters) - In a first for European drug research, scientists have launched a clinical trial of an anti-HIV biotech medicine produced using genetically modified tobacco -- a plant better known for ruining human health.